Qsymia (phentermine/topiramate extended-release)

phentermine/topiramate extended-release · Vivus, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Qsymia (phentermine/topiramate extended-release), covering 2025-10-31 to 2025-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity [EARLY_Phase 1]